STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation
{{output}}
Immunostimulatory therapies based on pattern recognition receptors (PRRs) have emerged as an effective approach in the fight against cancer, with the ability to recruit tumor-specific lymphocytes in a low-immunogenicity tumor environment. The agonist cyclic di... ...